AQP4 and amyotrophic lateral sclerosis: We observed that these preparations express low levels of AQP4, suggesting that they should be suited to investigate the functional impact of AQP4 up-regulation, a situation that might be expected in astrocytes generated from iPSCs derived from ALS patients.